Compare conditions

Put any two — or three — conditions side by side, adult or pediatric, to spot the look-alike differences fast, row by row.

Benign Prostatic Hyperplasia

—

In one line

·The prostate gland slowly grows larger with age and squeezes the urethra (the tube that carries urine out), so the bladder must push harder to empty.

—

Normal physiology

·The bladder is a stretchy, balloon-like bag that stores urine. When it is full, the detrusor muscle (the smooth muscle in the bladder wall) squeezes and pushes urine through the urethra—the tube that carries urine out of your body. The prostate gland is a small, walnut-shaped organ that wraps around the first part of the urethra, right where it exits the bladder.

—

What goes wrong

·The prostate slowly grows larger over years, especially in the transition zone (the inner part of the gland closest to the urethra). Because the prostate wraps around the urethra like a donut, the growing tissue squeezes inward and narrows the tube. At the same time, smooth muscle inside the prostate and bladder neck becomes tighter because of increased alpha-1 adrenergic tone (the 'fight-or-flight' chemical signal that tightens muscle), adding even more squeeze. So the urethra gets narrower from two directions—extra tissue pushing in and extra muscle tension clamping down.

—

Hallmark signs

·Weak urinary stream
·Hesitancy (trouble starting to pee)
·Intermittent stream (stop-and-go flow)
·Feeling that the bladder isn't empty after peeing
·Urinary frequency (peeing more than 8 times a day)
·Waking at night to urinate (Nocturia) (waking up 2 or more times at night to pee)
·Urgency (sudden, strong need to pee that is hard to hold)
·Blood in the urine (Hematuria) (blood you can see in the urine, making it pink or red)

—

Red flags · escalate now

·Acute urinary retention: sudden inability to pee with severe pain low in the belly and a bladder you can feel as a hard bulge above the pubic bone—needs emergency catheter (thin tube) placed through the urethra to drain the bladder right away.
·Repeated bladder infections (cystitis) or fever with pain when peeing—leftover urine becomes a breeding ground for bacteria, and infection can climb to the kidneys (pyelonephritis) or spread into the blood (urosepsis), which is life-threatening.
·Blood in the urine (hematuria) that keeps coming back or does not go away—must check for bladder cancer, kidney stones, and prostate cancer with imaging and cystoscopy (camera inside the bladder).
·Rising creatinine on a blood test or swollen kidneys (hydronephrosis) on ultrasound or CT—means backup pressure from the blocked bladder is traveling up the ureters and damaging the kidneys (obstructive nephropathy), which can lead to kidney failure.
·Hard, lumpy, or uneven prostate felt during digital rectal exam, or PSA (prostate-specific antigen blood test) that jumps up fast or stays very high—raises strong concern for prostate cancer and requires MRI and biopsy.

—

Workup

·Post-void residual (PVR) volume by bladder ultrasound or catheter measurement
·Urinalysis with microscopy
·Serum prostate-specific antigen (PSA)
·Serum creatinine and estimated glomerular filtration rate (eGFR)
·Uroflowmetry (measures the speed and pattern of urine flow during voluntary voiding)
·AUA Symptom Index (AUASI) or International Prostate Symptom Score (IPSS) questionnaire

—

Treatment

·Watchful waiting with behavioral modifications: timed voiding every 2–3 hours during the day, limit fluids after 6 PM, reduce caffeine and alcohol, practice double voiding (urinate, wait 30 seconds, try again)
·Alpha-1 adrenergic blockers: tamsulosin 0.4 mg daily, alfuzosin 10 mg daily, silodosin 8 mg twice daily, doxazosin (titrated to 4–8 mg daily), or terazosin (titrated to 5–10 mg daily)
·5-alpha-reductase inhibitors (5-ARIs): finasteride 5 mg daily or dutasteride 0.5 mg daily
·Combination therapy: alpha-blocker (e.g., tamsulosin) plus 5-alpha-reductase inhibitor (finasteride or dutasteride)
·Phosphodiesterase-5 (PDE5) inhibitor: tadalafil 5 mg once daily
·Anticholinergic (e.g., oxybutynin, tolterodine) or beta-3 agonist (mirabegron) added to alpha-blocker in men with persistent urgency and frequency despite obstruction relief
·Minimally invasive or surgical procedures: transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HoLEP), prostatic urethral lift (UroLift), water vapor thermal therapy (Rezūm), or prostatic artery embolization (PAE)

—

NCLEX trap

·Never give antihistamines or decongestants to a man with BPH (enlarged prostate). Both have anticholinergic effects — they block the nerve signals that tell the bladder muscle to squeeze. This can trigger acute urinary retention, where the man suddenly cannot pee at all. His bladder overfills like a water balloon ready to pop, and urine backs up into the kidneys, causing swelling (hydronephrosis) and possible kidney damage.
·Tamsulosin is an alpha-blocker. It relaxes the smooth muscle wrapped around the prostate and bladder neck — like loosening a tight belt around a garden hose — so urine can flow easier. It does NOT shrink the prostate. Finasteride (a 5-alpha-reductase inhibitor, or 5-ARI) is the drug that shrinks the prostate. It blocks testosterone from turning into dihydrotestosterone (DHT, the hormone that makes the prostate grow). Shrinkage takes 6 to 12 months, per AUA guidelines.
·Finasteride cuts PSA (prostate-specific antigen, a blood test used to screen for prostate cancer) roughly in half after 6 to 12 months. If you see PSA equals 2.0 in a man on finasteride, multiply by 2 to get the true value (4.0) before deciding if it is normal or worrisome. AUA guidelines say always adjust for this drug effect when interpreting PSA results.
·BPH is benign — not cancer. The prostate grows, but the cells are normal. Prostate cancer is malignant — the cells are abnormal and can spread. A man can have BPH and still develop prostate cancer separately. One does not turn into the other. Always screen for cancer with digital rectal exam (DRE, where the provider feels the prostate through the rectal wall) and PSA blood test, using shared decision-making per USPSTF and AUA guidelines.
·Post-void residual (how much urine is left in the bladder after you pee) over 100 to 200 mL is abnormal and shows incomplete emptying. But not every high PVR needs surgery. First, try medical therapy: alpha-blockers like tamsulosin (to relax the exit), 5-ARIs like finasteride (to shrink the prostate), or both. Surgery (TURP, laser, UroLift) is reserved for men who fail medical therapy or develop complications like recurrent retention, bladder stones, hydronephrosis (kidney swelling from backpressure), or recurrent urinary tract infections, per AUA guidelines.

—

Install Maldek by Hill as an app — studies work even offline